A new study has given the researchers a ray of light in the battle to safeguard people from the most widespread virus, HIV-1. Through this study, the researchers have found a new vaccine that seems to be appropriate and safe and induces an immune in human beings as well as the rhesus monkeys. This research is yet at its early stage.
As a part of this study, the HIV vaccine was tested on three hundred ninety-three people. The subjects came from around twelve clinics from all over the world encompassing east Africa, South Africa, Thailand, and the United States. All the subjects of the study received what is known as “mosaic” vaccine. The subjects were reportedly aged in between eighteen to fifty years and were healthy, free from HIV. They received 4 vaccinations through a period of forty-eight weeks. All of the vaccine combinations turned out safe and produced an anti-HIV immunity.
The co-author of this study, DR. Dan H. Barouch, at the Harvard Medical School, said in a statement, “I would say that we are pleased with these data so far, but we have to interpret the data cautiously.” Further, Barouch, the Director of the Center for Virology and Vaccine Research, added, “We have to acknowledge that developing an HIV vaccine is an unprecedented challenge, and we will not know for sure whether this vaccine will protect humans.”
This success has opened the gate for the vaccine to move forward for the further testing processes. According to the received reports, the vaccine would now be tested on a larger mass of individuals. This HIV-1 vaccine reportedly is the fifth concept to have reached this further in around forty years of the HIV pandemic.
Near about 1.8 million people get affected with HIV virus per year and nearly thirty-seven million individuals are living with the virus globally. In such a scenario, the need for finding a vaccine is essential and also difficult.
Dr. Carlos del Rio, the Co-principal Investigator at the Emory-CDC HIV Clinical Trials Unit, said in a statement, “It’s a very interesting study. Obviously, the search for an HIV vaccine is very elusive.”
The findings of this new study have been published in the The Lancet journal on Friday 6th June.